Production (Stage)
Semler Scientific, Inc.
SMLR
$44.32
-$0.61-1.36%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -28.82% | -8.13% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -28.82% | -8.13% | |||
| Cost of Revenue | -14.97% | -4.67% | |||
| Gross Profit | -30.17% | -8.46% | |||
| SG&A Expenses | 17.70% | 10.42% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.82% | 5.02% | |||
| Operating Income | -138.14% | -30.07% | |||
| Income Before Tax | -329.83% | 411.00% | |||
| Income Tax Expenses | -401.69% | 339.95% | |||
| Earnings from Continuing Operations | -321.54% | 420.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -321.54% | 420.70% | |||
| EBIT | -138.14% | -30.07% | |||
| EBITDA | -135.80% | -29.14% | |||
| EPS Basic | -285.47% | 356.59% | |||
| Normalized Basic EPS | -213.38% | 348.07% | |||
| EPS Diluted | -297.39% | 374.43% | |||
| Normalized Diluted EPS | -220.90% | 363.57% | |||
| Average Basic Shares Outstanding | 19.45% | 14.03% | |||
| Average Diluted Shares Outstanding | 12.02% | 10.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||